ENO1 and bladder transitional cell carcinoma: The results demonstrated that HS3ST3B1, FMOD, CSPG4, ALDH1A1, CYP1B1, and ENO1 exhibited significantly higher expression levels in the high-grade BLCA group (Figure 5B).